Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
438
days
MARCHF6 orchestrates hepatic lipid homeostasis by targeting SREBP1 for ER-associated degradation
Authors
Yanan Xu; Tongpeng Yue; Uyanga Batbold; Assa Magassa; Kun Liu; Liping Jiang; Dechen Liu; Long Nguyen Hoang Do; Xiaolei Liu; Ling Yang; Jun Yu; Sheng Wu; Deyu Fang; Xiaofeng Yang; Hong Wang; Xiaoyu Zhang; Ling Leng; Juncheng WeiShow moreShow less
Affiliations
Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA; Stem Cell and Regenerative Medicine Lab, National infrastructures for Translational Medicine and State Key Laboratory for Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of Chemistry, Northwestern University, Evanston, Illinois, 60208, USA; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, 60607, USA; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China; Lemole Center for Integrated Lymphatics and Vascular Research, Department of Cardiovascular Sciences, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140, USA; Medical Genetics & Molecular Biochemistry, Lewis Kats School of Medicine, Temple University, Philadelphia, PA, USAShow moreShow less
179
days
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares
Authors
Heiner Wedemeyer; Ed Gane; Kosh Agarwal; Ömer Fehmi Tabak; Xavier Forns; Ulus Salih Akarca; Viacheslav Morozov; Soo Aleman; Maria Buti; Gurdal Yilmaz; Pietro Lampertico; John Jezorwski; Thomas N. Kakuda; Adam Bakala; Nonko Pehlivanov; Thierry Verbinnen; Oliver Lenz; Michael BiermerShow moreShow less
Affiliations
Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hanover, Germany, Excellence Cluster RESIST, D-SOLVE Consortium, Hannover, German Center for Infection Research (DZIF) Partner Site Hannover-Braunschweig, Braunschweig, Germany; New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand; Institute of Liver Studies, King’s College Hospital, London, England; Istanbul University-Cerrahpasa, Department of Infectious Diseases, Istanbul, Turkey; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, CIBEREHD, Spain; Division of Gastroenterology, Department of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey; Medical Company Hepatolog Ltd, Samara, Russia; Department of Infectious Diseases, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden; Hospital General Universitari Valle Hebron and CIBER-EHD del Instituto Carlos III, Barcelona, Spain; Trabzon Karadeniz Technical University Farabi Hospital, Trabzon, Turkey; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Johnson & Johnson, Titusville, NJ, USA; Johnson & Johnson Research & Development, LLC, Brisbane, CA, USA; Johnson & Johnson, Beerse, BelgiumShow moreShow less
279
days
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid
Authors
Hai-Lin Xiong; Qi Zhao; Shu-Qing Liu; Li-Lin Chen; Mei-Tong Nie; Xia-Lu Hong; Chen-Hong Ding; Ru Huang; Nan Jiang; Fei Chen; Yu-Hao Song; Xin Zhang; Ke-Qi Wang; Chang-Peng Zhu; Wei-Fen XieShow moreShow less
Affiliations
Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaShow moreShow less
259
days
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models
Authors
Katharina B. Kuentzel; Samuel A.J. Trammell; Anna S. Hassing; Ivan Bradić; Michelle Damgaard; Emma B. Fals; Katja T. Michler; Matthew Dooley; Jens C.B. Jacobsen; Malte P. Suppli; Mikkel P. Werge; Cameron J. Mitchell; Nicolai J. Wewer Albrechtsen; Lise L. Glud; Filip K. Knop; James F. Markworth; Martin R. Larsen; Matthew P. Gillum; Jonas T. Treebak; Jesmund Dalli; Steen Larsen; Trisha J. GrevengoedShow moreShow less
Affiliations
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Clinical Biochemistry, Copenhagen University Hospital—Bispebjerg, Copenhagen, Denmark; Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark; School of Kinesiology, The University of British Columbia, Canada; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Present address: Novo Nordisk, Bagsværd, Denmark; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark; Department of Animal Sciences, Purdue University, West Lafayette, IN, USA; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, UK; Institute of Sports Medicine Copenhagen, Department of Orthopedic Surgery M, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Denmark; Clinical Research Centre, Medical University of Bialystok, Bialystok, PolandShow moreShow less
180
days
A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma
Authors
David J. Taggart; Shivani Mahajan; Maxime A. Gallant; Itai Pinkoviezky; Jianfeng Xu; Allison J. Sorg; Curt C. Roberts; Dmitri Slinkov; Emmanuel C. Gorospe; Abdullah Mubarak; Bal Raj Bhandari; Bradley Freilich; Nadege Gunn; Ju Dong Yang; John H. Smith; Ziad H. Younes; Roniel Cabrera; Humberto Aguilar; Hrishikesh Samant; Wei Li; Richard A. Van Etten; Mindie H. NguyenShow moreShow less
Affiliations
Helio Genomics, Inc., Irvine, California, USA; Laboratory for Advanced Medicine & Health Ltd. (LAMH), Beijing, China; Texas Gastro Research, El Paso, Texas, USA; Liver Center of Texas, Dallas, Texas, USA; Delta Research Partners, LLC, Bastrop, Louisiana, USA; Kansas City Research Institute, Kansas City, Missouri, USA; Velocity Clinical Research, Waco, Texas, USA; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Digestive and Liver Disease Specialists, Norfolk, VA, USA; Gastro One, Germantown, Tennessee, USA; Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, University of Florida, Gainesville, Florida, USA; Louisiana Research Center, Shreveport, Louisiana, USA; Department of Gastroenterology and Hepatology, Ochsner Health System, New Orleans, Louisiana, USA; Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, California, USA; Chao Family Comprehensive Cancer Center and Department of Medicine, School of Medicine, University of California, Irvine, California, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, California, USA; Department of Epidemiology and Population Health, Stanford University Medical Center, California, USA; Stanford Cancer Institute, Stanford University Medical Center, California, USAShow moreShow less
274
days
CD34+ cell-derived endothelial cells orchestrate vascular and immune remodeling in the transplanted liver
Authors
Ruihan Chen; Xinqiang Li; Pengwei Zhu; Xuewen Yi; Ting Wang; Hui Chen; Xueyin Huang; Guoguo Ye; Jingyu Jiang; Meiching Ong; Liujun Jiang; Yali Li; Siyi Zhong; Yangyan He; Rong Fan; Bohuan Zhang; Hongjun Li; Jinzhen Cai; Shusen Zheng; Qingbo Xu; Qi Ling; Hongkun ZhangShow moreShow less
Affiliations
Department of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao, China; Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China; Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China; Liangzhu Laboratory, Zhejiang University, Hangzhou, China; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days